Publications des scientifiques de l'IRD

Havlir D., Lockman S., Ayles H., Larmarange Joseph, Chamie G., Gaolathe T., Iwuji C., Fidler S., Kamya M., Floyd S., Moore J., Hayes R., Petersen M., Dabis F., Universal Test Treat Trials UT3 Consortium. (2020). What do the Universal Test and Treat trials tell us about the path to HIV epidemic control ?. Journal of the International AIDS Society, 23 (2), p. e25455 [7 p.].

Titre du document
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control ?
Année de publication
2020
Type de document
Article référencé dans le Web of Science WOS:000518595100011
Auteurs
Havlir D., Lockman S., Ayles H., Larmarange Joseph, Chamie G., Gaolathe T., Iwuji C., Fidler S., Kamya M., Floyd S., Moore J., Hayes R., Petersen M., Dabis F., Universal Test Treat Trials UT3 Consortium
Source
Journal of the International AIDS Society, 2020, 23 (2), p. e25455 [7 p.]
Introduction Achieving HIV epidemic control globally will require new strategies to accelerate reductions in HIV incidence and mortality. Universal test and treat (UTT) was evaluated in four randomized population-based trials (BCPP/Ya Tsie, HPTN 071/PopART, SEARCH, ANRS 12249/TasP) conducted in sub-Saharan Africa (SSA) during expanded antiretroviral treatment (ART) eligibility by World Health Organization guidelines and the UNAIDS 90-90-90 campaign. Discussion These three-year studies were conducted in Botswana, Zambia, Uganda, Kenya and South Africa in settings with baseline HIV prevalence from 4% to 30%. Key observations across studies were: (1) Universal testing (implemented via a variety of home and community-based testing approaches) achieved >90% coverage in all studies. (2) When coupled with robust linkage to HIV care, rapid ART start and patient-centred care, UTT achieved among the highest reported population levels of viral suppression in SSA. Significant gains in population-level viral suppression were made in regions with both low and high baseline population viral load; however, viral suppression gains were not uniform across all sub-populations and were lower among youth. (3) UTT resulted in marked reductions in community HIV incidence when universal testing and robust linkage were present. However, HIV elimination targets were not reached. In BCPP and HPTN 071, annualized HIV incidence was approximately 20% to 30% lower in the intervention (which included universal testing) compared to control arms (no universal testing). In SEARCH (where both arms had universal testing), incidence declined 32% over three years. (4) UTT reduced HIV associated mortality by 23% in the intervention versus control communities in SEARCH, a study in which mortality was comprehensively measured. Conclusions These trials provide strong evidence that UTT inclusive of universal testing increases population-level viral suppression and decreases HIV incidence and mortality faster than the status quo in SSA and should be adapted at a sub-country level as a public health strategy. However, more is needed, including integration of new prevention interventions into UTT, in order to reach UNAIDS HIV elimination targets.
Plan de classement
Santé : généralités [050] ; Entomologie médicale / Parasitologie / Virologie [052] ; Santé : aspects socioculturels, économiques et politiques [056]
Description Géographique
BOTSWANA ; ZAMBIE ; OUGANDA ; KENYA ; AFRIQUE DU SUD ; AFRIQUE SUBSAHARIENNE
Localisation
Fonds IRD [F B010078031]
Identifiant IRD
fdi:010078031
Contact
  • Coordonnées :
    IST / IRD Ile-de-France
    32 avenue Henri Varagnat
    93140 Bondy Cedex
    France
    Horizon Pleins textes
  •